ConductScience.org, home

Paper35683032

Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.

Wang S and 4 others. Int J Mol Sci, 2022. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α. Papers, record 35683032. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35683032

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.62
iCite
Revised in PubMed
2024-08-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang SSaini
2Yadav AKAnil Kumarhttps://orcid.org/0000-0001-9324-2735
3Han JYJin-Yihttps://orcid.org/0000-0003-2074-4472
4Ahn KSKeun Soo
5Jang BCByeong-Churl

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bile Duct NeoplasmsMajor topic
CholangiocarcinomaMajor topic
Bile Ducts, Intrahepatic
Casein Kinase II
Caspase 9
Cell Line, Tumor
Eukaryotic Initiation Factor-2
Humans
Naphthyridines
Phenazines

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022R1A2C4001769National Research Foundation of KoreaPubMed

Source PubMed

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132606456Cholangiocarcinoma 2020: the next horizon in mechanisms and management.Nat Rev Gastroenterol Hepatol2020https://conductscience.org/library/papers/32606456PubMed
225081716High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis.Asian Pac J Cancer Prev2014https://conductscience.org/library/papers/25081716PubMed
330316146Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma.Transl Oncol2019https://conductscience.org/library/papers/30316146PubMed
427479180Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia.Leukemia2017https://conductscience.org/library/papers/27479180PubMed
524609900Translational regulator eIF2α in tumor.Tumour Biol2014https://conductscience.org/library/papers/24609900PubMed
626151455The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours.Br J Cancer2015https://conductscience.org/library/papers/26151455PubMed
721174434Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer.J Med Chem2011https://conductscience.org/library/papers/21174434PubMed
831641101The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells.Oncogenesis2019https://conductscience.org/library/papers/31641101PubMed
926508039
Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry.
Hepatol Res2016https://conductscience.org/library/papers/26508039PubMed
1021940327Hypoxia inducible factor expression in intrahepatic cholangiocarcinoma.Hepatogastroenterology2011https://conductscience.org/library/papers/21940327PubMed
1116489027Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.Cancer Res2006https://conductscience.org/library/papers/16489027PubMed
1223925046Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia.Leukemia2014https://conductscience.org/library/papers/23925046PubMed
1327480717Measuring Survival of Adherent Cells with the Colony-Forming Assay.Cold Spring Harb Protoc2016https://conductscience.org/library/papers/27480717PubMed
1425153725Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.Oncotarget2014https://conductscience.org/library/papers/25153725PubMed
1526911335Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.BMC Nephrol2016https://conductscience.org/library/papers/26911335PubMed
1623828693Overexpressions of CK2β and XIAP are associated with poor prognosis of patients with cholangiocarcinoma.Pathol Oncol Res2014https://conductscience.org/library/papers/23828693PubMed
1717461440Multi-disciplinary treatment for cholangiocellular carcinoma.World J Gastroenterol2007https://conductscience.org/library/papers/17461440PubMed
1834944749The Immune Regulatory Role of Protein Kinase CK2 and Its Implications for Treatment of Cancer.Biomedicines2021https://conductscience.org/library/papers/34944749PubMed
1931789392Anti‑survival and pro‑apoptotic effects of meridianin C derivatives on MV4‑11 human acute myeloid leukemia cells.Int J Oncol2020https://conductscience.org/library/papers/31789392PubMed
2033148274Eukaryotic translation initiation factors as promising targets in cancer therapy.Cell Commun Signal2020https://conductscience.org/library/papers/33148274PubMed

See all 42 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40280109Anticancer effects of salvianolic acid A through multiple signaling pathways (Review).Mol Med Rep2025https://conductscience.org/library/papers/40280109PubMed
39925432Single-cell and spatial transcriptomics reveal pre-metastatic subsets and therapeutic targets in penile carcinoma.iScience2025https://conductscience.org/library/papers/39925432PubMed
39862423Targeting the IKZF1/BCL-2 axis as a novel therapeutic strategy for treating acute T-cell lymphoblastic leukemia.Cancer Biol Ther2025https://conductscience.org/library/papers/39862423PubMed
39618935Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy.J Inflamm Res2024https://conductscience.org/library/papers/39618935PubMed
39300073The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39300073PubMed
38730642Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma.Cancers (Basel)2024https://conductscience.org/library/papers/38730642PubMed
37022795Long noncoding RNA HIKER regulates erythropoiesis in Monge's disease via CSNK2B.J Clin Invest2023https://conductscience.org/library/papers/37022795PubMed
35806278Anti-adipogenic and Pro-lipolytic Effects on 3T3-L1 Preadipocytes by CX-4945, an Inhibitor of Casein Kinase 2.Int J Mol Sci2022https://conductscience.org/library/papers/35806278PubMed

Download CSV of cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ARNT405PubTator's text mininghttps://conductscience.org/library/genes/405NCBI Gene
ATF4468PubTator's text mininghttps://conductscience.org/library/genes/468NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CASP9842PubTator's text mininghttps://conductscience.org/library/genes/842NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
CSNK2A21459PubTator's text mininghttps://conductscience.org/library/genes/1459NCBI Gene
CSNK2B1460PubTator's text mininghttps://conductscience.org/library/genes/1460NCBI Gene
EIF2A83939PubTator's text mininghttps://conductscience.org/library/genes/83939NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
HLA-DRB43126PubTator's text mininghttps://conductscience.org/library/genes/3126NCBI Gene
HSPA53309PubTator's text mininghttps://conductscience.org/library/genes/3309NCBI Gene
MCL14170PubTator's text mininghttps://conductscience.org/library/genes/4170NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
PTK2B2185PubTator's text mininghttps://conductscience.org/library/genes/2185NCBI Gene
RNASE16035PubTator's text mininghttps://conductscience.org/library/genes/6035NCBI Gene
SIK1150094PubTator's text mininghttps://conductscience.org/library/genes/150094NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene
STAT5A6776PubTator's text mininghttps://conductscience.org/library/genes/6776NCBI Gene
TNFRSF10A8797PubTator's text mininghttps://conductscience.org/library/genes/8797NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35683032

GET https://conductscience.org/api/papers/v1/35683032/references?page=2